EXECUTIVE STEERING COMMITTEE ADVISOR CONSULTING AGREEMENTExecutive Steering Committee Advisor Consulting Agreement • May 13th, 2021 • BioCardia, Inc. • Biological products, (no disgnostic substances) • California
WHEREAS, the SPONSOR is evaluating an investigational device called the CardiAMP System (“Study Device”) for use in patients with post myocardial infarction heart failure in a study in accordance with the Protocol entitled: “Randomized Controlled Pivotal Trial of Autologous Bone Marrow Cells Using the CardiAMP System in Patients with Post Myocardial Infarction Heart Failure,”, as may be amended from time to time, referred to as the CardiAMP Heart Failure Trial, which is incorporated herein by reference as part of this Agreement and the terms and conditions contained herein collectively (“Study”) on its behalf;
